EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C30H45NO7P.Na |
| Net Charge | 0 |
| Average Mass | 585.654 |
| Monoisotopic Mass | 585.28313 |
| SMILES | [H][C@@]1(C2CCCCC2)C[C@@H](C(=O)[O-])N(C(=O)CP(=O)(CCCCc2ccccc2)OC(OC(=O)CC)C(C)C)C1.[Na+] |
| InChI | InChI=1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35);/q;+1/p-1/t25-,26+,30?,39?;/m1./s1 |
| InChIKey | TVTJZMHAIQQZTL-HREVRLCXSA-M |
| Roles Classification |
|---|
| Biological Role: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). |
| Applications: | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1). prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| fosinopril sodium (CHEBI:5164) has part fosinopril(1−) (CHEBI:59125) |
| fosinopril sodium (CHEBI:5164) has role antihypertensive agent (CHEBI:35674) |
| fosinopril sodium (CHEBI:5164) has role EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor (CHEBI:35457) |
| fosinopril sodium (CHEBI:5164) has role prodrug (CHEBI:50266) |
| fosinopril sodium (CHEBI:5164) is a organic sodium salt (CHEBI:38700) |
| IUPAC Name |
|---|
| sodium (2S,4S)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate |
| Synonym | Source |
|---|---|
| fosinopril sodium | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| D00622 | KEGG DRUG |
| US2006160772 | Patent |
| WO02088149 | Patent |
| Registry Numbers | Sources |
|---|---|
| Beilstein:6840563 | Beilstein |
| CAS:88889-14-9 | KEGG DRUG |
| CAS:88889-14-9 | ChemIDplus |
| Citations |
|---|